Journal of Pharmaceutical Health Care and Sciences
Overview
Journal of Pharmaceutical Health Care and Sciences is a scientific journal, published by Biomed Central since 2015 in English. The journal's country of origin is United Kingdom and its primary focus area is pharmacology.
Details
Details
Abbr.
J Pharm Health Care Sci
Publisher
Biomed Central
Start
2015
End
Continuing
e-ISSN
2055-0294
Country
United Kingdom
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 14363
10
SJR / Ranks: 11694
312
CiteScore / Ranks: 12222
1.30
Recent Articles
11.
Fukuda Y, Ito R, Kakihana M, Takahashi T, Kanemoto T, Sahara T, et al.
J Pharm Health Care Sci
. 2025 Feb;
11(1):10.
PMID: 39901218
Background: Stroke is a leading cause of death, reducing disability-free life expectancy. After acute treatment, patients require rehabilitation to prevent recurrence. Continued use of medication is crucial for recurrence prevention...
12.
Kan Y, Doi M, Uesawa Y
J Pharm Health Care Sci
. 2025 Jan;
11(1):8.
PMID: 39885610
Background: The Anticholinergic Risk Scale and Total Anticholinergic Load were developed to assess the risks associated with anticholinergic drugs. Recently, the Japan Anticholinergic Risk Scale was introduced; however, the total...
13.
Uchida K, Takahama K, Higashi K, Kusano Y, Matsumoto K, Nakagawa Y, et al.
J Pharm Health Care Sci
. 2025 Jan;
11(1):9.
PMID: 39885566
Background: Cataract surgeries are increasing annually, making appropriate medical management essential. The routine use of systemic antimicrobial agents for preventing surgical site infections lacks strong evidence and may increase the...
14.
Okamura N, Katagiri A, Komori T, Kawanabe K, Koike H, Sahashi Y, et al.
J Pharm Health Care Sci
. 2025 Jan;
11(1):7.
PMID: 39881383
Background: Pharmaceutical formularies play a crucial role in guiding medication use by balancing clinical effectiveness and cost efficiency. Although formulary implementation has been increasing in Japan, comprehensive evaluations of its...
15.
Nishita Y, Taga M, Arakawa N, Ishida T, Ochiai S, Ono H, et al.
J Pharm Health Care Sci
. 2025 Jan;
11(1):6.
PMID: 39871376
Background: Toxic epidermal necrolysis (TEN), a severe cutaneous hypersensitivity reaction induced particularly by drugs, is diagnosed when there is a fever of ≥ 38 °C, mucocutaneous symptoms, a rash with...
16.
Nagano Y, Aoki H, David J, Kondo N, Aizawa M, Sumita T, et al.
J Pharm Health Care Sci
. 2025 Jan;
11(1):5.
PMID: 39871315
Background: Remdesivir is recommended to treat hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is known to affect glucose metabolism in individuals with and without diabetes. However, little is known...
17.
Ishii M, Ozone S, Masumoto S, Maeno T
J Pharm Health Care Sci
. 2025 Jan;
11(1):4.
PMID: 39849660
Background: Community pharmacists play a crucial role in promoting medication safety within the community healthcare team. Effective communication by community pharmacists with other health professionals is essential to facilitate the...
18.
Miyata Y, Yamaguchi R, Yamamoto T, Kishida T, Ikeuchi K, Harada H, et al.
J Pharm Health Care Sci
. 2025 Jan;
11(1):3.
PMID: 39844338
Background: Ensitrelvir is a novel SARS-CoV-2 3-chymotrypsin-like protease inhibitor, similar to nirmatrelvir/ritonavir. Several case reports have demonstrated the efficacy of 3-chymotrypsin-like protease inhibitors in treating prolonged coronavirus disease 2019 (COVID-19)...
19.
Birhanu S, Tamiru M, Kedir H, Tadesse T
J Pharm Health Care Sci
. 2025 Jan;
11(1):2.
PMID: 39789652
Background: Antithrombotic medications are essential for the management of abnormal clot formation. However, their availability, pricing, and affordability in Ethiopia, particularly in Addis Ababa, have not been comprehensively studied. Methods:...
20.
Futamura A, Koseki T, Iida J, Suzuki A, Muroi N, Myotoku M, et al.
J Pharm Health Care Sci
. 2025 Jan;
11(1):1.
PMID: 39780288
No abstract available.